ArticleMedicina (Kaunas, Lithuania)2025
Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn's Disease: A Prospective Cohort Study.
Luis G Guijarro, Patricia de Castro-Martínez, María Chaparro, Julio Acero-Sanz, Diego de León, Iván Guerra, Marisa Iborra, José Luis Cabriada, Luis Bujanda, Cristina Alba and 14 more
Abstract readMulticenter StudyComparative Study
In one paragraphArticle in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
24 authors.
Patricia de Castro-MartínezRamón y Cajal Institute of Sanitary Research (IRYCIS), 28034 Madrid, Spain.ORCID 0009-0002-8591-6116 María ChaparroCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 28029 Madrid, Spain.ORCID 0000-0002-9275-4242 Diego de LeónDepartment of Medicine and Medical Specialties, Faculty of Medicine and Health Sciences, University of Alcalá, 28805 Alcalá de Henares, Spain.
Iván GuerraGastroenterology Department, Hospital Universitario de Fuenlabrada, 28942 Fuenlabrada, Spain.ORCID 0000-0002-5175-2515 José Luis CabriadaGastroenterology Unit, Hospital Universitario de Galdakano, 48960 Galdakano, Spain.ORCID 0000-0002-3068-5659 Cristina AlbaGastroenterology Unit, Hospital Universitario Clínico San Carlos and IdISSC, 28040 Madrid, Spain.
Valle García-SánchezGastroenterology Unit, Hospital Universitario Reina Sofía/Universidad de Córdoba, 14004 Córdoba, Spain.
Ignacio Marín-JiménezGastroenterology Unit, Hospital Universitario Gregorio Marañón e IiSGM, 28007 Madrid, Spain.
Manuel Barreiro-de AcostaGastroenterology Unit, Hospital Universitario Clínico de Santiago, 15706 Santiago de Compostela, Spain.ORCID 0000-0001-5915-1477 Isabel VeraGastroenterology Unit, Hospital Universitario Puerta de Hierro Majadahonda, 28222 Majadahonda, Spain.
María Dolores Martín-ArranzGastroenterology Unit, Hospital Universitario La Paz, Instituto de Investigación Hospital Universitario La Paz (IdiPaz), Universidad Autónoma de Madrid, 28046 Madrid, Spain.ORCID 0000-0002-1872-0917 Fernando GomollónGastroenterology Unit, Hospital Clínico Universitario, Lozano Blesa, IIS Aragón, 50009 Zaragoza, Spain.ORCID 0000-0003-0076-3529 Joaquín HinojosaGastroenterology Unit, Hospital Vithas Virgen del Consuelo, 46007 Valencia, Spain.
Borja Hernández-BreijoDepartment of System Biology, University of Alcalá, 28805 Alcalá de Henares, Spain.
Javier P GisbertCentro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), 28029 Madrid, Spain.ORCID 0000-0003-2090-3445 PREDICROHN Study Group from GETECCU
Funding
Asociación Española de Gastroenterología (AEG) 49/2015Comunidad de Madrid. Spain MITIC-CM-2022Instituto de Salud Carlos III. PI12/02557, PI13/00041
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
AdalimumabCrohn DiseaseInfliximabAdultCohort StudiesFemaleHumansMaleMiddle AgedProspective StudiesTreatment OutcomeAdalimumabInfliximabadalimumabC-reactive proteinCrohn’s diseasefibrinogenimmunogenicityinfliximab
Identifiers
PMID41470167
PMCPMC12734427
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390